Drug intelligence / Profile preview

Glycolic acid

Development stage
Phase 4
Lead developer
PureTech Scientific
Modality
Small Molecules
Administration
Topical
01

Overview

Glycolic acid is a naturally occurring alpha hydroxy acid (AHA) derived primarily from sugarcane, though it can also be found in other fruits and synthesized industrially[1][8]. It is widely used in topical skincare products for its exfoliating properties. Glycolic acid works by weakening the bonds between dead skin cells in the outermost layer of the skin, promoting their removal and revealing fresher skin underneath[3][5]. This process helps improve skin texture, reduce signs of aging such as wrinkles and sun damage, treat acne and acne scars, lighten dark spots (melasma), and address hyperpigmentation[1][3][5]. Mechanistically, glycolic acid acts as a keratolytic agent with anti-inflammatory and antioxidant effects; it may also stimulate collagen production by increasing hyaluronic acid levels in the outer layers of the skin[3][6]. Its small molecular size allows for deep penetration into the epidermis. Glycolic acid is not considered a pharmaceutical drug but rather an active ingredient in cosmetic formulations.

Brand names
GlyDerm
Other names
Hydroxyacetic acid
02

Targets

NLRC4 (NLR family CARD domain containing 4)

Beyond the preview

Go deeper on Glycolic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycolic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call